Status:
COMPLETED
Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events
Lead Sponsor:
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Conditions:
Dyslipidemia
Cardiovascular Diseases
Eligibility:
All Genders
18+ years
Brief Summary
High and Very High Risk cardiovascular patient journeys seems to vary from country to country, and current understanding of the process is incomplete. This real-life observational study which document...
Detailed Description
Suffering from hypercholesterolemia is a major health concern in Europe. Appropriate medical treatment lowers low density lipoprotein cholesterol and reduces the incidence of clinical cardiovascular e...
Eligibility Criteria
Inclusion
- Very High Risk and High Risk dyslipidemic patients requiring LMTs
- Not simultaneously participating in any interventional study
- Providing written informed consent for participation in the study (Informed consent form)
- Life expectancy \> 1 year
Exclusion
- Not applicable; non-interventional study
Key Trial Info
Start Date :
March 17 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 11 2022
Estimated Enrollment :
9559 Patients enrolled
Trial Details
Trial ID
NCT04271280
Start Date
March 17 2020
End Date
April 11 2022
Last Update
February 20 2024
Active Locations (540)
Enter a location and click search to find clinical trials sorted by distance.
1
Krankenhaus St. Josef Braunau GmbH
Braunau am Inn, Austria, 5280
2
LKH-Univ. Klinikum Graz
Graz, Austria, 8036
3
Medizinische Universität Graz
Graz, Austria, 8036
4
Medizinische Universität Innsbruck
Innsbruck, Austria, 6020